EmendoBio develops advanced CRISPR gene-editing technologies, proprietary nucleases, and AI-driven genome engineering solutions for therapeutic development, biotechnology research, and genetic medicine applications.
Still not listed on TechPartner?
Showcase your company to Israel's technology ecosystem.
EmendoBio
